Bladder rhabdomyosarcoma is a malignant mesenchymal tumor showing striated muscle differentiation. It is the most common bladder tumor of childhood, typically occurring in children under 5 years. The most common histological subtype is embryonal rhabdomyosarcoma; its polypoid variant is known as sarcoma botryoides (grape-like), forming grape-like polypoid masses protruding into the bladder lumen. Clinically presents with hematuria, urinary retention, recurrent UTI, and palpable pelvic mass. Bladder rhabdomyosarcoma in adults is very rare and shows aggressive course. On imaging, it appears as a polypoid or lobulated mass extending into the bladder lumen; shows heterogeneous enhancement on CT and MRI.
Age Range
1-10
Peak Age
4
Gender
Equal
Prevalence
Rare
Rhabdomyosarcoma originates from primitive mesenchymal cells showing striated muscle differentiation. The embryonal subtype consists of primitive rhabdomyoblasts that mimic muscle formation during embryonic development. The sarcoma botryoides variant contains tumor cells concentrated in the submucosal cambium layer (Nicholson layer) — these cells form polypoid extensions toward the mucosal surface. Polypoid structures contain edematous, myxoid stroma and loose connective tissue — forming the basis of T2-hyperintense signal and low-enhancing areas on imaging. The grape-like appearance results from each polypoid extension dangling into the bladder lumen like an individual 'grape.' The tumor may invade the muscle layer and perivesical tissue. Metastasis typically develops late and hematogenously (lung, liver, bone). Presence of PAX-FOXO1 fusion genes (alveolar type) is a poor prognostic marker; embryonal type lacks this fusion gene.
T2-hyperintense grape-cluster-like lobulated polypoid mass protruding into bladder lumen — pathognomonic imaging finding of sarcoma botryoides. Each polypoid lobule gives bright T2 signal due to myxoid stroma. This appearance is diagnostic in the context of childhood bladder mass.
Lobulated polypoid mass protruding into bladder lumen in portal venous phase — heterogeneous structure at low-intermediate density (20-50 HU). Solid areas enhance moderately, myxoid areas minimally enhance. Mass may originate from bladder trigone or posterior wall. Perivesical invasion seen in advanced stage. Mass size generally large (>3-5 cm).
Report Sentence
Lobulated polypoid mass protruding into bladder lumen is observed, consistent with rhabdomyosarcoma (sarcoma botryoides) in childhood context.
Prominently hyperintense, lobulated polypoid mass in the bladder lumen on T2-weighted images — reflecting high water content of myxoid stroma. Solid tumor areas show intermediate signal. Individual grape-like polypoid lobules are prominent on T2. Degree of bladder wall invasion evaluated on T2 — if intact muscle layer preserved as low-signal band, no invasion.
Report Sentence
Grape-cluster-like hyperintense lobulated polypoid mass in the bladder lumen on T2-weighted images; consistent with sarcoma botryoides.
Diffusion restriction in solid tumor components on DWI; facilitated diffusion in myxoid areas. ADC values heterogeneous — solid areas 0.8-1.2, myxoid areas >1.5 × 10⁻³ mm²/s. DWI useful in distinguishing solid from myxoid components and evaluating treatment response.
Report Sentence
Diffusion restriction in solid components of the mass with facilitated diffusion in myxoid areas on DWI.
Heterogeneous enhancement on contrast-enhanced MRI — solid components enhance prominently while myxoid/edematous areas minimally enhance. Cambium layer (peripheral tumor cell concentration) may show peripheral enhancement pattern.
Report Sentence
Prominent enhancement in solid components with minimal enhancement of myxoid areas on contrast-enhanced images.
Lobulated, polypoid, hypoechoic-heterogeneous mass in bladder lumen on B-mode US. Myxoid areas hypoechoic, solid areas more echogenic. Vascularity may be demonstrated in solid areas on Doppler. US usually the initial detection tool and further evaluation with MRI required.
Report Sentence
Lobulated polypoid mass in bladder lumen on US; MRI evaluation recommended for childhood bladder tumor (rhabdomyosarcoma).
Large mass with heterogeneous density filling bladder lumen or infiltrating bladder wall in pelvis on non-contrast CT. Low-density areas represent myxoid component, intermediate-density areas solid tumor. Calcification is rare. Bone destruction may be seen in advanced cases.
Report Sentence
Large heterogeneous mass filling bladder lumen in pelvis; rhabdomyosarcoma should be considered in childhood context.
Criteria
Polypoid variant of embryonal rhabdomyosarcoma. Grape-like growth.
Distinct Features
Most common form in childhood. Polypoid lobular mass. Dominant myxoid stroma. Good prognosis (compared to other subtypes).
Criteria
Solid type embryonal rhabdomyosarcoma. Does not show polypoid growth pattern.
Distinct Features
More solid, less myxoid. More aggressive enhancement. Earlier wall invasion.
Criteria
Rare subtype. PAX-FOXO1 fusion gene positive. More aggressive biology.
Distinct Features
More homogeneous solid mass, less myxoid component. More aggressive local invasion and early metastasis. Poor prognosis.
Distinguishing Feature
Urothelial carcinoma in adults; rhabdomyosarcoma in children. Urothelial carcinoma papillary/sessile mass; rhabdomyosarcoma lobulated botryoid mass. Myxoid components of rhabdomyosarcoma brighter on T2.
Distinguishing Feature
Inverted papilloma benign, small (<3 cm), smooth-bordered polypoid lesion; rhabdomyosarcoma large, lobulated, and aggressive.
Distinguishing Feature
Paraganglioma submucosal hypervascular mass; rhabdomyosarcoma lobulated myxoid mass. Prominent vascularity (flow void) in paraganglioma; myxoid T2 hyperintensity in rhabdomyosarcoma.
Distinguishing Feature
Leiomyoma T2-hypointense homogeneous solid mass; rhabdomyosarcoma T2-hyperintense heterogeneous lobulated mass. Leiomyoma in adults, rhabdomyosarcoma in children.
Urgency
emergentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralBladder rhabdomyosarcoma treatment requires multidisciplinary approach. Current standard treatment is neoadjuvant chemotherapy (VAC: vincristine + actinomycin D + cyclophosphamide) followed by surgery and radiotherapy if needed. Organ-sparing approach preferred when possible. Prognosis in children much better than adults — 5-year survival >80% for embryonal/botryoid type. Poor prognosis for alveolar type. Treatment protocols per COG (Children's Oncology Group) and CWS (Cooperative Weichteilsarkom Studie) guidelines.
Bladder RMS is the most common subtype of childhood genitourinary RMS. The embryonal (botryoid) subtype has a good prognosis with multimodal treatment (chemotherapy + surgery +/- radiotherapy) achieving 80-90% five-year survival. The alveolar subtype is more aggressive with poorer prognosis. Diagnosis is confirmed by biopsy. Treatment follows Children's Oncology Group (COG) protocols. Early diagnosis and treatment allow bladder-sparing approaches.